Pharma is behind the curve in digital marketing. What does the industry need to do to fully release the power of digital communications? Driven by customer demand, digital marketing has grown in importance and is now...

As gene therapies for major diseases accelerate from the development pipeline, how can pharma exploit near-term opportunities and protect its business going forward? As gene therapies for major diseases accelerate from...

The Digital Therapeutics field is exploding: what does pharma need to know - and do - to get on board? Evidence-based and reimbursed digital therapeutics (DTx) are now part of the health delivery landscape. They hold...

How to secure commercial advantage in the speciality drugs arena What is the secret of commercial success for high cost specialty drugs? More specifically, what do the companies that overcome affordability and value...

Technical advances are ushering in a new era for companion diagnostics. What does Pharma need know? The introduction of liquid biopsies and advances in next generation sequencing are just the latest developments driving...

Ensuring payer support, delivering stakeholder benefit and generating commercial returns: Pharma's growing orphan drug challenge Rising competition and closer scrutiny by hard-pressed payers are just two of the trends...

Can nanomedicines really offer pharma a compelling alternative approach to precision medicines? Delivering accurate diagnosis for clinicians, safer medicines for patients and lower costs through reduced waste and costly...

Payers love digital technologies that reduce health costs and deliver patient benefit–but who should pick up the tab? Digital technology is revolutionising healthcare from advanced electronic medical records and...